:

OPAY TAPS CITI, DEUTSCHE, JPMORGAN FOR US IPO

INDUSTRY DESK1 MIN READ
FRI, MAY 1, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Nigeria-focused payments platform Opay has enlisted Citigroup, Deutsche Bank, and JPMorgan Chase to underwrite its planned initial public offering in the United States.

Opay Digital Services Ltd., backed by SoftBank, is moving forward with its IPO preparations by securing three major investment banks as advisors. The trio will guide the company through the public listing process. Opay operates as a digital payments platform primarily serving Nigeria, one of Africa's largest economies and mobile money markets. The company has positioned itself as a fintech player in the region, offering payment and financial services to consumers and businesses. The engagement of Citi, Deutsche Bank, and JPMorgan signals institutional confidence in Opay's market position and growth potential. These banks typically manage large-scale IPOs and bring significant distribution networks. SoftBank's backing provides substantial financial resources and strategic support. The Japanese conglomerate has invested heavily in fintech and emerging market technologies. No timeline for the IPO has been disclosed. Opay will need to meet SEC requirements and complete regulatory filings before any public offering can proceed.

■ SOURCES

Bloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

YESTERDAYAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

YESTERDAYAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

YESTERDAYAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.